Detalhe da pesquisa
1.
Phase I Trial of Intratumoral Injection of CCL21 Gene-Modified Dendritic Cells in Lung Cancer Elicits Tumor-Specific Immune Responses and CD8+ T-cell Infiltration.
Clin Cancer Res
; 23(16): 4556-4568, 2017 Aug 15.
Artigo
Inglês
| MEDLINE | ID: mdl-28468947
2.
CCL21 Chemokine Therapy for Lung Cancer.
Int Trends Immun
; 1(1): 10-15, 2013 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-25264541